Plasmapheresis in Rasmussen's encephalitis
- 1 January 1996
- journal article
- Published by Wolters Kluwer Health in Neurology
- Vol. 46 (1), 242-246
- https://doi.org/10.1212/wnl.46.1.242
Abstract
Article abstract-Rasmussen9s encephalitis (RE) is a progressive childhood disorder characterized by intractable focal seizures, hemiplegia, dementia, and inflammatory histopathology. The process is typically limited to one cerebral hemisphere. We report four patients with pathologically confirmed RE who were treated with repeated plasmapheresis. Three patients exhibited repeated, dramatic, transient responses to plasmapheresis, manifested by reduced seizure frequency and improved neurologic function. One patient exhibited marginal improvement after treatment with plasmapheresis. These observations indicate that circulating factors, likely autoantibodies, are pathogenic in at least some patients with RE and suggest that RE is an autoimmune disease. Plasmapheresis may be a useful adjunctive therapy in RE, specifically for treatment of patients with acute deteriorations such as status epilepticus, and can also aid in assessment of residual function in the diseased hemisphere before surgical resection. NEUROLOGY 1996;46: 242-246Keywords
This publication has 4 references indexed in Scilit:
- Workshop summaryAnnals of Neurology, 1994
- Megadose corticosteroids in multiple sclerosisNeurology, 1994
- Update on the syndrome of "chronic encephalitis" and epilepsyCleveland Clinic Journal of Medicine, 1989
- Neuropsychological Assessment of ChildrenJournal of Child Neurology, 1987